Loading…
Leukemia Inhibitory Factor-Dependent Transcriptional Activation in Embryonic Stem Cells
STAT transcription factors are induced by a number of growth factors and cytokines. Within minutes of induction, the STAT proteins are phosphorylated on tyrosine and serine residues and translocated to the nucleus, where they bind to their DNA targets. The leukemia inhibitory factor (LIF) mediates p...
Saved in:
Published in: | The Journal of cell biology 1997-09, Vol.138 (6), p.1207-1217 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c530t-bda1a3476afc514b70ebcb9d69adabc512a9dc0f420ba8164a356c5eb42444c93 |
---|---|
cites | cdi_FETCH-LOGICAL-c530t-bda1a3476afc514b70ebcb9d69adabc512a9dc0f420ba8164a356c5eb42444c93 |
container_end_page | 1217 |
container_issue | 6 |
container_start_page | 1207 |
container_title | The Journal of cell biology |
container_volume | 138 |
creator | Boeuf, Hélène Hauss, Charlotte De Graeve, Fabienne Baran, Nathalie Kedinger, Claude |
description | STAT transcription factors are induced by a number of growth factors and cytokines. Within minutes of induction, the STAT proteins are phosphorylated on tyrosine and serine residues and translocated to the nucleus, where they bind to their DNA targets. The leukemia inhibitory factor (LIF) mediates pleiotropic and sometimes opposite effects both in vivo and in cultured cells. It is known, for example, to prevent differentiation of embryonic stem (ES) cells in vitro. To get insights into LIF-regulated signaling in ES cells, we have analyzed protein-binding and transcriptional properties of STAT recognition sites in ES cells cultivated in the presence and in the absence of LIF. We have detected a specific LIF-regulated DNA-binding activity implicating the STAT3 protein. We show that STAT3 phosphorylation is essential for this LIF-dependent DNA-binding activity. The possibility that ERK2 or a closely related protein kinase, whose activity is modulated in a LIF-dependent manner, contributes to this phosphorylation is discussed. Finally, we show that the multimerized STAT3-binding DNA element confers LIF responsiveness to a minimal thymidine kinase promoter. This, together with our observation that overexpression of STAT3 dominant-negative mutants abrogates this LIF responsiveness, clearly indicates that STAT3 is involved in LIF-regulated transcriptional events in ES cells. Finally, stable expression of such a dominant negative mutant of STAT3 induces morphological differentiation of ES cells despite continuous LIF supply. Our results suggest that STAT3 is a critical target of the LIF signaling pathway, which maintains pluripotent cell proliferation. |
doi_str_mv | 10.1083/jcb.138.6.1207 |
format | article |
fullrecord | <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2132559</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>1618164</jstor_id><sourcerecordid>1618164</sourcerecordid><originalsourceid>FETCH-LOGICAL-c530t-bda1a3476afc514b70ebcb9d69adabc512a9dc0f420ba8164a356c5eb42444c93</originalsourceid><addsrcrecordid>eNpdkUtr3DAUhUVpSSZpt101YLLIzq7etjeFMM0LBrpoSpfiStY0mtrSRLID8-8rM0PSZHWRztHh6H4IfSa4IrhhXzdGV4Q1lawIxfU7tCCC47IhHL9HC4wpKVtBxTE6SWmDMeY1Z0foqKVt09b1Av1e2emvHRwUd_7BaTeGuCuuweRZfrdb6zvrx-I-gk8muu3ogoe-uDSje4L5UDhfXA067oJ3pvg52qFY2r5PH9GHNfTJfjrMU_Tr-up-eVuuftzcLS9XpREMj6XugADjtYS1EYTrGlttdNvJFjrQ-YpC2xm85hRraIjkwIQ0wmpOOeemZafo2z53O-nBdia3jdCrbXQDxJ0K4NRrxbsH9Sc8KUoYFWIOuDgExPA42TSqwSWTvwDehikpIhklRIpsPH9j3IQp5m2knFVjKRmT2VTtTSaGlKJdPzchWM28VOalMi8l1cwrPzj7v_-z_QAo61_2-iZlJC9pkszbYP8Adk-cog</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217066336</pqid></control><display><type>article</type><title>Leukemia Inhibitory Factor-Dependent Transcriptional Activation in Embryonic Stem Cells</title><source>Alma/SFX Local Collection</source><creator>Boeuf, Hélène ; Hauss, Charlotte ; De Graeve, Fabienne ; Baran, Nathalie ; Kedinger, Claude</creator><creatorcontrib>Boeuf, Hélène ; Hauss, Charlotte ; De Graeve, Fabienne ; Baran, Nathalie ; Kedinger, Claude</creatorcontrib><description>STAT transcription factors are induced by a number of growth factors and cytokines. Within minutes of induction, the STAT proteins are phosphorylated on tyrosine and serine residues and translocated to the nucleus, where they bind to their DNA targets. The leukemia inhibitory factor (LIF) mediates pleiotropic and sometimes opposite effects both in vivo and in cultured cells. It is known, for example, to prevent differentiation of embryonic stem (ES) cells in vitro. To get insights into LIF-regulated signaling in ES cells, we have analyzed protein-binding and transcriptional properties of STAT recognition sites in ES cells cultivated in the presence and in the absence of LIF. We have detected a specific LIF-regulated DNA-binding activity implicating the STAT3 protein. We show that STAT3 phosphorylation is essential for this LIF-dependent DNA-binding activity. The possibility that ERK2 or a closely related protein kinase, whose activity is modulated in a LIF-dependent manner, contributes to this phosphorylation is discussed. Finally, we show that the multimerized STAT3-binding DNA element confers LIF responsiveness to a minimal thymidine kinase promoter. This, together with our observation that overexpression of STAT3 dominant-negative mutants abrogates this LIF responsiveness, clearly indicates that STAT3 is involved in LIF-regulated transcriptional events in ES cells. Finally, stable expression of such a dominant negative mutant of STAT3 induces morphological differentiation of ES cells despite continuous LIF supply. Our results suggest that STAT3 is a critical target of the LIF signaling pathway, which maintains pluripotent cell proliferation.</description><identifier>ISSN: 0021-9525</identifier><identifier>EISSN: 1540-8140</identifier><identifier>DOI: 10.1083/jcb.138.6.1207</identifier><identifier>PMID: 9298977</identifier><identifier>CODEN: JCLBA3</identifier><language>eng</language><publisher>United States: Rockefeller University Press</publisher><subject>Acute-Phase Proteins - metabolism ; Animals ; Antibodies ; Antibody Specificity ; Binding Sites - physiology ; Blastocyst - cytology ; Calcium-Calmodulin-Dependent Protein Kinases - metabolism ; Cell Differentiation - drug effects ; Cell Differentiation - genetics ; Cell Division - drug effects ; Cell Division - genetics ; Cell Line ; Cell lines ; Cells ; Cellular biology ; Cellular differentiation ; DNA-Binding Proteins - immunology ; DNA-Binding Proteins - metabolism ; Embryonic stem cells ; Embryos ; Gene Expression Regulation, Developmental - drug effects ; Gene Expression Regulation, Enzymologic - drug effects ; Growth Inhibitors - chemistry ; Growth Inhibitors - genetics ; Growth Inhibitors - pharmacology ; Interleukin-6 ; Leukemia ; Leukemia Inhibitory Factor ; Lymphokines - chemistry ; Lymphokines - genetics ; Lymphokines - pharmacology ; Mice ; Mitogen-Activated Protein Kinase 1 ; Mutagenesis - physiology ; Myeloid cells ; PC12 cells ; Phosphoproteins - immunology ; Phosphorylation ; Pluripotent stem cells ; Promoter Regions, Genetic - drug effects ; Promoter Regions, Genetic - physiology ; Protein-Serine-Threonine Kinases - metabolism ; Proteins ; Proto-Oncogene Proteins c-fos - genetics ; Recombinant Fusion Proteins - genetics ; STAT3 Transcription Factor ; Stem cells ; Stem Cells - chemistry ; Stem Cells - cytology ; Stem Cells - enzymology ; Trans-Activators - immunology ; Trans-Activators - metabolism ; Transcription, Genetic - drug effects ; Tyrosine - metabolism</subject><ispartof>The Journal of cell biology, 1997-09, Vol.138 (6), p.1207-1217</ispartof><rights>Copyright 1997 The Rockefeller University Press</rights><rights>Copyright Rockefeller University Press Sep 22, 1997</rights><rights>1997</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c530t-bda1a3476afc514b70ebcb9d69adabc512a9dc0f420ba8164a356c5eb42444c93</citedby><cites>FETCH-LOGICAL-c530t-bda1a3476afc514b70ebcb9d69adabc512a9dc0f420ba8164a356c5eb42444c93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9298977$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boeuf, Hélène</creatorcontrib><creatorcontrib>Hauss, Charlotte</creatorcontrib><creatorcontrib>De Graeve, Fabienne</creatorcontrib><creatorcontrib>Baran, Nathalie</creatorcontrib><creatorcontrib>Kedinger, Claude</creatorcontrib><title>Leukemia Inhibitory Factor-Dependent Transcriptional Activation in Embryonic Stem Cells</title><title>The Journal of cell biology</title><addtitle>J Cell Biol</addtitle><description>STAT transcription factors are induced by a number of growth factors and cytokines. Within minutes of induction, the STAT proteins are phosphorylated on tyrosine and serine residues and translocated to the nucleus, where they bind to their DNA targets. The leukemia inhibitory factor (LIF) mediates pleiotropic and sometimes opposite effects both in vivo and in cultured cells. It is known, for example, to prevent differentiation of embryonic stem (ES) cells in vitro. To get insights into LIF-regulated signaling in ES cells, we have analyzed protein-binding and transcriptional properties of STAT recognition sites in ES cells cultivated in the presence and in the absence of LIF. We have detected a specific LIF-regulated DNA-binding activity implicating the STAT3 protein. We show that STAT3 phosphorylation is essential for this LIF-dependent DNA-binding activity. The possibility that ERK2 or a closely related protein kinase, whose activity is modulated in a LIF-dependent manner, contributes to this phosphorylation is discussed. Finally, we show that the multimerized STAT3-binding DNA element confers LIF responsiveness to a minimal thymidine kinase promoter. This, together with our observation that overexpression of STAT3 dominant-negative mutants abrogates this LIF responsiveness, clearly indicates that STAT3 is involved in LIF-regulated transcriptional events in ES cells. Finally, stable expression of such a dominant negative mutant of STAT3 induces morphological differentiation of ES cells despite continuous LIF supply. Our results suggest that STAT3 is a critical target of the LIF signaling pathway, which maintains pluripotent cell proliferation.</description><subject>Acute-Phase Proteins - metabolism</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Antibody Specificity</subject><subject>Binding Sites - physiology</subject><subject>Blastocyst - cytology</subject><subject>Calcium-Calmodulin-Dependent Protein Kinases - metabolism</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Differentiation - genetics</subject><subject>Cell Division - drug effects</subject><subject>Cell Division - genetics</subject><subject>Cell Line</subject><subject>Cell lines</subject><subject>Cells</subject><subject>Cellular biology</subject><subject>Cellular differentiation</subject><subject>DNA-Binding Proteins - immunology</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Embryonic stem cells</subject><subject>Embryos</subject><subject>Gene Expression Regulation, Developmental - drug effects</subject><subject>Gene Expression Regulation, Enzymologic - drug effects</subject><subject>Growth Inhibitors - chemistry</subject><subject>Growth Inhibitors - genetics</subject><subject>Growth Inhibitors - pharmacology</subject><subject>Interleukin-6</subject><subject>Leukemia</subject><subject>Leukemia Inhibitory Factor</subject><subject>Lymphokines - chemistry</subject><subject>Lymphokines - genetics</subject><subject>Lymphokines - pharmacology</subject><subject>Mice</subject><subject>Mitogen-Activated Protein Kinase 1</subject><subject>Mutagenesis - physiology</subject><subject>Myeloid cells</subject><subject>PC12 cells</subject><subject>Phosphoproteins - immunology</subject><subject>Phosphorylation</subject><subject>Pluripotent stem cells</subject><subject>Promoter Regions, Genetic - drug effects</subject><subject>Promoter Regions, Genetic - physiology</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Proteins</subject><subject>Proto-Oncogene Proteins c-fos - genetics</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>STAT3 Transcription Factor</subject><subject>Stem cells</subject><subject>Stem Cells - chemistry</subject><subject>Stem Cells - cytology</subject><subject>Stem Cells - enzymology</subject><subject>Trans-Activators - immunology</subject><subject>Trans-Activators - metabolism</subject><subject>Transcription, Genetic - drug effects</subject><subject>Tyrosine - metabolism</subject><issn>0021-9525</issn><issn>1540-8140</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNpdkUtr3DAUhUVpSSZpt101YLLIzq7etjeFMM0LBrpoSpfiStY0mtrSRLID8-8rM0PSZHWRztHh6H4IfSa4IrhhXzdGV4Q1lawIxfU7tCCC47IhHL9HC4wpKVtBxTE6SWmDMeY1Z0foqKVt09b1Av1e2emvHRwUd_7BaTeGuCuuweRZfrdb6zvrx-I-gk8muu3ogoe-uDSje4L5UDhfXA067oJ3pvg52qFY2r5PH9GHNfTJfjrMU_Tr-up-eVuuftzcLS9XpREMj6XugADjtYS1EYTrGlttdNvJFjrQ-YpC2xm85hRraIjkwIQ0wmpOOeemZafo2z53O-nBdia3jdCrbXQDxJ0K4NRrxbsH9Sc8KUoYFWIOuDgExPA42TSqwSWTvwDehikpIhklRIpsPH9j3IQp5m2knFVjKRmT2VTtTSaGlKJdPzchWM28VOalMi8l1cwrPzj7v_-z_QAo61_2-iZlJC9pkszbYP8Adk-cog</recordid><startdate>19970922</startdate><enddate>19970922</enddate><creator>Boeuf, Hélène</creator><creator>Hauss, Charlotte</creator><creator>De Graeve, Fabienne</creator><creator>Baran, Nathalie</creator><creator>Kedinger, Claude</creator><general>Rockefeller University Press</general><general>The Rockefeller University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>19970922</creationdate><title>Leukemia Inhibitory Factor-Dependent Transcriptional Activation in Embryonic Stem Cells</title><author>Boeuf, Hélène ; Hauss, Charlotte ; De Graeve, Fabienne ; Baran, Nathalie ; Kedinger, Claude</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c530t-bda1a3476afc514b70ebcb9d69adabc512a9dc0f420ba8164a356c5eb42444c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Acute-Phase Proteins - metabolism</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Antibody Specificity</topic><topic>Binding Sites - physiology</topic><topic>Blastocyst - cytology</topic><topic>Calcium-Calmodulin-Dependent Protein Kinases - metabolism</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Differentiation - genetics</topic><topic>Cell Division - drug effects</topic><topic>Cell Division - genetics</topic><topic>Cell Line</topic><topic>Cell lines</topic><topic>Cells</topic><topic>Cellular biology</topic><topic>Cellular differentiation</topic><topic>DNA-Binding Proteins - immunology</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Embryonic stem cells</topic><topic>Embryos</topic><topic>Gene Expression Regulation, Developmental - drug effects</topic><topic>Gene Expression Regulation, Enzymologic - drug effects</topic><topic>Growth Inhibitors - chemistry</topic><topic>Growth Inhibitors - genetics</topic><topic>Growth Inhibitors - pharmacology</topic><topic>Interleukin-6</topic><topic>Leukemia</topic><topic>Leukemia Inhibitory Factor</topic><topic>Lymphokines - chemistry</topic><topic>Lymphokines - genetics</topic><topic>Lymphokines - pharmacology</topic><topic>Mice</topic><topic>Mitogen-Activated Protein Kinase 1</topic><topic>Mutagenesis - physiology</topic><topic>Myeloid cells</topic><topic>PC12 cells</topic><topic>Phosphoproteins - immunology</topic><topic>Phosphorylation</topic><topic>Pluripotent stem cells</topic><topic>Promoter Regions, Genetic - drug effects</topic><topic>Promoter Regions, Genetic - physiology</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Proteins</topic><topic>Proto-Oncogene Proteins c-fos - genetics</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>STAT3 Transcription Factor</topic><topic>Stem cells</topic><topic>Stem Cells - chemistry</topic><topic>Stem Cells - cytology</topic><topic>Stem Cells - enzymology</topic><topic>Trans-Activators - immunology</topic><topic>Trans-Activators - metabolism</topic><topic>Transcription, Genetic - drug effects</topic><topic>Tyrosine - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boeuf, Hélène</creatorcontrib><creatorcontrib>Hauss, Charlotte</creatorcontrib><creatorcontrib>De Graeve, Fabienne</creatorcontrib><creatorcontrib>Baran, Nathalie</creatorcontrib><creatorcontrib>Kedinger, Claude</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of cell biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boeuf, Hélène</au><au>Hauss, Charlotte</au><au>De Graeve, Fabienne</au><au>Baran, Nathalie</au><au>Kedinger, Claude</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leukemia Inhibitory Factor-Dependent Transcriptional Activation in Embryonic Stem Cells</atitle><jtitle>The Journal of cell biology</jtitle><addtitle>J Cell Biol</addtitle><date>1997-09-22</date><risdate>1997</risdate><volume>138</volume><issue>6</issue><spage>1207</spage><epage>1217</epage><pages>1207-1217</pages><issn>0021-9525</issn><eissn>1540-8140</eissn><coden>JCLBA3</coden><abstract>STAT transcription factors are induced by a number of growth factors and cytokines. Within minutes of induction, the STAT proteins are phosphorylated on tyrosine and serine residues and translocated to the nucleus, where they bind to their DNA targets. The leukemia inhibitory factor (LIF) mediates pleiotropic and sometimes opposite effects both in vivo and in cultured cells. It is known, for example, to prevent differentiation of embryonic stem (ES) cells in vitro. To get insights into LIF-regulated signaling in ES cells, we have analyzed protein-binding and transcriptional properties of STAT recognition sites in ES cells cultivated in the presence and in the absence of LIF. We have detected a specific LIF-regulated DNA-binding activity implicating the STAT3 protein. We show that STAT3 phosphorylation is essential for this LIF-dependent DNA-binding activity. The possibility that ERK2 or a closely related protein kinase, whose activity is modulated in a LIF-dependent manner, contributes to this phosphorylation is discussed. Finally, we show that the multimerized STAT3-binding DNA element confers LIF responsiveness to a minimal thymidine kinase promoter. This, together with our observation that overexpression of STAT3 dominant-negative mutants abrogates this LIF responsiveness, clearly indicates that STAT3 is involved in LIF-regulated transcriptional events in ES cells. Finally, stable expression of such a dominant negative mutant of STAT3 induces morphological differentiation of ES cells despite continuous LIF supply. Our results suggest that STAT3 is a critical target of the LIF signaling pathway, which maintains pluripotent cell proliferation.</abstract><cop>United States</cop><pub>Rockefeller University Press</pub><pmid>9298977</pmid><doi>10.1083/jcb.138.6.1207</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9525 |
ispartof | The Journal of cell biology, 1997-09, Vol.138 (6), p.1207-1217 |
issn | 0021-9525 1540-8140 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2132559 |
source | Alma/SFX Local Collection |
subjects | Acute-Phase Proteins - metabolism Animals Antibodies Antibody Specificity Binding Sites - physiology Blastocyst - cytology Calcium-Calmodulin-Dependent Protein Kinases - metabolism Cell Differentiation - drug effects Cell Differentiation - genetics Cell Division - drug effects Cell Division - genetics Cell Line Cell lines Cells Cellular biology Cellular differentiation DNA-Binding Proteins - immunology DNA-Binding Proteins - metabolism Embryonic stem cells Embryos Gene Expression Regulation, Developmental - drug effects Gene Expression Regulation, Enzymologic - drug effects Growth Inhibitors - chemistry Growth Inhibitors - genetics Growth Inhibitors - pharmacology Interleukin-6 Leukemia Leukemia Inhibitory Factor Lymphokines - chemistry Lymphokines - genetics Lymphokines - pharmacology Mice Mitogen-Activated Protein Kinase 1 Mutagenesis - physiology Myeloid cells PC12 cells Phosphoproteins - immunology Phosphorylation Pluripotent stem cells Promoter Regions, Genetic - drug effects Promoter Regions, Genetic - physiology Protein-Serine-Threonine Kinases - metabolism Proteins Proto-Oncogene Proteins c-fos - genetics Recombinant Fusion Proteins - genetics STAT3 Transcription Factor Stem cells Stem Cells - chemistry Stem Cells - cytology Stem Cells - enzymology Trans-Activators - immunology Trans-Activators - metabolism Transcription, Genetic - drug effects Tyrosine - metabolism |
title | Leukemia Inhibitory Factor-Dependent Transcriptional Activation in Embryonic Stem Cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A19%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leukemia%20Inhibitory%20Factor-Dependent%20Transcriptional%20Activation%20in%20Embryonic%20Stem%20Cells&rft.jtitle=The%20Journal%20of%20cell%20biology&rft.au=Boeuf,%20H%C3%A9l%C3%A8ne&rft.date=1997-09-22&rft.volume=138&rft.issue=6&rft.spage=1207&rft.epage=1217&rft.pages=1207-1217&rft.issn=0021-9525&rft.eissn=1540-8140&rft.coden=JCLBA3&rft_id=info:doi/10.1083/jcb.138.6.1207&rft_dat=%3Cjstor_pubme%3E1618164%3C/jstor_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c530t-bda1a3476afc514b70ebcb9d69adabc512a9dc0f420ba8164a356c5eb42444c93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=217066336&rft_id=info:pmid/9298977&rft_jstor_id=1618164&rfr_iscdi=true |